Eledon Pharmaceuticals, Inc.
ELDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404281
No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Eledon Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 32 | 31 | −1 |
| Shares | 7.01M | 6.54M | −470.0K (−6.7%) |
| Value | $27.6M | $15.9M | −$11.7M (−42.2%) |
New holders (2)
Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 4,638 | $11.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 19 | $0 | 0.00% |
Sold out (3)
Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Veritable, L.P. | 33,092 | $130.0K |
| Envestnet Asset Management Inc | 16,726 | $66.0K |
| Millennium Management LLC | 11,951 | $47.0K |